Jonathan Stuart Kaplan

Array ( [id] => 5141361 [patent_doc_number] => 20070003577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections' [patent_app_type] => utility [patent_app_number] => 11/475237 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6842 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003577.pdf [firstpage_image] =>[orig_patent_app_number] => 11475237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585014 [patent_doc_number] => 20090104216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Peptide-Based Influenza Vaccine Formulation' [patent_app_type] => utility [patent_app_number] => 11/921436 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9044 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104216.pdf [firstpage_image] =>[orig_patent_app_number] => 11921436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608437 [patent_doc_number] => 20060269953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Novel hepatitis B virus' [patent_app_type] => utility [patent_app_number] => 11/440977 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2478 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269953.pdf [firstpage_image] =>[orig_patent_app_number] => 11440977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608515 [patent_doc_number] => 20060270031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Cell separation method and kit using phase separation' [patent_app_type] => utility [patent_app_number] => 11/439916 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5111 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270031.pdf [firstpage_image] =>[orig_patent_app_number] => 11439916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4531148 [patent_doc_number] => 07871621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Anti-HBs monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 11/435835 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4705 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/871/07871621.pdf [firstpage_image] =>[orig_patent_app_number] => 11435835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619392 [patent_doc_number] => 20060188925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Feline CTLA-4 nucleic acid and polypeptides' [patent_app_type] => utility [patent_app_number] => 11/414707 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 40142 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188925.pdf [firstpage_image] =>[orig_patent_app_number] => 11414707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8269943 [patent_doc_number] => 08211443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof' [patent_app_type] => utility [patent_app_number] => 11/911097 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 25340 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753483 [patent_doc_number] => 20060222632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Disinfection of foodstuffs' [patent_app_type] => utility [patent_app_number] => 11/367967 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4742 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222632.pdf [firstpage_image] =>[orig_patent_app_number] => 11367967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850641 [patent_doc_number] => 20060233832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases' [patent_app_type] => utility [patent_app_number] => 11/365210 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9583 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233832.pdf [firstpage_image] =>[orig_patent_app_number] => 11365210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839393 [patent_doc_number] => 20080279878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis' [patent_app_type] => utility [patent_app_number] => 11/908474 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21345 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279878.pdf [firstpage_image] =>[orig_patent_app_number] => 11908474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859139 [patent_doc_number] => 20080267989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Hiv Gp-41-Membrane Proximal Region Arrayed On Hepatitis B Surface Antigen Particles as Novel Antigens' [patent_app_type] => utility [patent_app_number] => 11/816069 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23716 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267989.pdf [firstpage_image] =>[orig_patent_app_number] => 11816069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5785235 [patent_doc_number] => 20060204986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Immunogen' [patent_app_type] => utility [patent_app_number] => 11/353025 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 15386 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204986.pdf [firstpage_image] =>[orig_patent_app_number] => 11353025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010483 [patent_doc_number] => 20070280962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'HBV core antigen particles with multiple immunogenic components attached via peptid ligands' [patent_app_type] => utility [patent_app_number] => 11/338397 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9981 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280962.pdf [firstpage_image] =>[orig_patent_app_number] => 11338397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843435 [patent_doc_number] => 20060121580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Binding molecules against SARS-coronavirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/337300 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 44526 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121580.pdf [firstpage_image] =>[orig_patent_app_number] => 11337300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694096 [patent_doc_number] => 20060154243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Antigenic peptides of SARS coronavirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/337226 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12462 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154243.pdf [firstpage_image] =>[orig_patent_app_number] => 11337226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922510 [patent_doc_number] => 20060240515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Soluble fragments of the SARS-CoV spike glycoprotein' [patent_app_type] => utility [patent_app_number] => 11/335197 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32581 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240515.pdf [firstpage_image] =>[orig_patent_app_number] => 11335197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236060 [patent_doc_number] => 20070128217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Antigenic peptides of SARS coronavirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/332820 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79765 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128217.pdf [firstpage_image] =>[orig_patent_app_number] => 11332820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119984 [patent_doc_number] => 20070141698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Microbial protein expression system utilizing plant viral coat protein' [patent_app_type] => utility [patent_app_number] => 11/311197 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4406 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141698.pdf [firstpage_image] =>[orig_patent_app_number] => 11311197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5650011 [patent_doc_number] => 20060135746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Dual inhibitors of HIV-1 gp-120 interactions' [patent_app_type] => utility [patent_app_number] => 11/305401 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1703 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135746.pdf [firstpage_image] =>[orig_patent_app_number] => 11305401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747872 [patent_doc_number] => 20060110803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Antigenic peptides of SARS coronavirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/295192 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11411 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110803.pdf [firstpage_image] =>[orig_patent_app_number] => 11295192 [rel_patent_id] =>[rel_patent_doc_number] =>)